Literature DB >> 19022151

Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.

Kenneth E Fleisher1, Steven Doty, Shailesh Kottal, Joan Phelan, Robert G Norman, Robert S Glickman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19022151     DOI： 10.1016/j.joms.2008.07.021

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  9 in total

Review 1.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

2.  Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Authors:  X Ji; S Pushalkar; Y Li; R Glickman; K Fleisher; D Saxena
Journal:  Oral Dis       Date:  2011-08-29       Impact factor: 3.511

3.  Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells.

Authors:  Pit Jacob Voss; Akihiko Matsumoto; Esteban Alvarado; Rainer Schmelzeisen; Fabian Duttenhöfer; Philipp Poxleitner
Journal:  Odontology       Date:  2017-02-20       Impact factor: 2.634

4.  Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.

Authors:  D Yoshiga; M Sasaguri; K Matsuo; S Kokuryou; M Habu; M Oda; M Kodama; H Tsurushima; O Sakaguchi; T Sakurai; J Tanaka; Y Morimoto; I Yoshioka; K Tominaga
Journal:  Osteoporos Int       Date:  2015-06-03       Impact factor: 4.507

5.  Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

Authors:  Hiroaki Shimamoto; Tristan R Grogan; Tomomi Tsujimoto; Naoya Kakimoto; Shumei Murakami; David Elashoff; Tara L Aghaloo; Sotirios Tetradis
Journal:  Dentomaxillofac Radiol       Date:  2017-12-15       Impact factor: 2.419

6.  Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case series.

Authors:  Petra Rugani; Stephan Acham; Barbara Kirnbauer; Astrid Truschnegg; Barbara Obermayer-Pietsch; Norbert Jakse
Journal:  Clin Oral Investig       Date:  2014-12-17       Impact factor: 3.573

Review 7.  Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.

Authors:  Sven Otto; Christoph Pautke; Sigurd Hafner; Ronny Hesse; Lea Franziska Reichardt; Gerson Mast; Michael Ehrenfeld; Carl-Peter Cornelius
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-05-31

Review 8.  The Therapeutic Effectiveness Using Fluorescence-Guided Surgery for MRONJ.

Authors:  Hongyuan Huang; Ning Zhao; Qingxiang Li; Qiao Qiao; Jianya Zhang; Chuanbin Guo; Yuxing Guo
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246

9.  Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature.

Authors:  F Longo; A Guida; C Aversa; E Pavone; G Di Costanzo; L Ramaglia; F Ionna
Journal:  Int J Dent       Date:  2014-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.